Azerbaijan vs Papua New Guinea: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Azerbaijan
52.0%
in 2024
Papua New Guinea
41.0%
in 2024
Azerbaijan rank
139th
Papua New Guinea rank
142nd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Azerbaijan
- Papua New Guinea
How they compare
Azerbaijan currently reports 52.0% against 41.0% in Papua New Guinea, a difference of 11.0%.
That makes Azerbaijan's figure about 1.3 times Papua New Guinea's.
Across all 10 years both countries report, Azerbaijan has been ahead every year.
Azerbaijan ranks 139th and Papua New Guinea ranks 142nd of 146 countries.
Azerbaijan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.6% | 29.2% | 44.4% | Azerbaijan |
| 2020s | 50.6% | 36.6% | 14.0% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Azerbaijan or Papua New Guinea?
- Azerbaijan, at 52.0% against 41.0% in Papua New Guinea as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Azerbaijan and Papua New Guinea?
- 11.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Papua New Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do Azerbaijan and Papua New Guinea rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Azerbaijan ranks 139th and Papua New Guinea ranks 142nd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.